OBJECTIVE: Studies, comparing several disease-prone and disease-resistant rat strains to elucidate the extent and severity of syndromes resembling human diseases are lacking. Therefore we studied the inbred rat strains BBaOK, BNaCrl, LEWaK and WKYaCrl in comparison with SHRaMol and WOKWaK rats as models of metabolic syndrome. DESIGN: Body weight and body mass index (BMI) were measured in 12 males of each strain at 14 weeks. In addition blood glucose, serum triglycerides, cholesterol, insulin and leptin were determined at 12, 13 and 14 weeks of age. RESULTS: In contrast to SHR animals, WOKW rats develop a severe metabolic syndrome including obesity, hyperleptinemia, hyperinsulinemia and dyslipidemia. CONCLUSION: We conclude that; (i) the choice of disease-resistant inbred rat strains as`healthy controls' for a disease-prone strain has to be carefully evaluated; (ii) in comparison with SHR, WOKW rats develop most if not all facets of the metabolic syndrome described in human and (iii) as with the human disease the syndrome in rats is polygenic.
Introduction
The metabolic syndrome includes a cluster of symptoms like obesity, glucose intolerance, hyperinsulinemia and insulin resistance, dyslipidemia and hypertension. The prevalence is estimated to be b 20% among adults and is a common health problem in industrialized countries. 1 ± 3 The metabolic syndrome is multifactorial, which complicates studies in humans. Therefore, there is interest in experimental models which may enable an in depth study of the cellular factors eliciting the metabolic syndrome. Several animal models are available, though not all symptoms occur in the same animal model. For instance, the spontaneously hypertensive rat (SHR) is proposed as a model of the insulin-resistance syndrome with respect to its insulin resistance, hypertriglyceridemia, abdominal obesity and hypertension. 4 ± 8 Similarly, the hereditary hypertriglyceridemic rat (hHTG) 9 and Wistar Ottawa Karlsburg rats (WOKW) 10 develop a metabolic syndrome-like disease. Whereas hHTG rats are described as hypertriglyceridemic with nutritionally inducible insulin resistance without obesity, the WOKW rats develop almost the entire cluster of symptoms, including moderately increased blood pressure. That not all symptoms occur in the same animal model is not a serious problem since not all patients with a metabolic syndrome manifest all elements of the symptom cluster. There is considerable individual variability in the extent and severity of the syndrome. The main problem in the use of animal models is the fact that there are no reference values to distinguish between normal and healthy on the one hand and pathological and ill on the other. The SHR, hHTG and WOKW rats are proposed to be models of human metabolic disease on the basis of comparative studies. However, one usually compares one disease-prone strain with one supposedly disease-resistant strain. In studies using SHR animals, WKY, BN or LEW rats are generally used as disease-resistant`control' strains. 4 ± 8,11,12 For WOKW rats the nondiabetic BBaOK rat derived from the same outbred Wistar rat stock as WOKW, is used as`control rat strain.' 10, 13 Studies, comparing several disease-prone and disease-resistant rat strains to assess the power of an animal model are lacking. This prompted us to study the inbred rat strains BBaOK, BN, LEW and WKY as disease-resistant`control strains' in comparison with the disease-prone SHR and WOKW rats under the same laboratory conditions to evaluate the extent and severity of the metabolic syndrome in both proposed models.
Material and methods

Animals
Groups of 12 males, mean age 13AE 1 weeks, were studied. Inbred rat strains BBaOK, LEWaK and WOKWaK were bred in our own animal facility, 14, 15 BNaCrl, WKYaCrl and SHRaMol were commercially obtained from Charles River Wiga GmbH (Crl, Sulzfeld, Germany) or Mollegaard Breeding Ltd (Mol, Lille Skensved, Denmark). BN, WKY and SHR were purchased at an age of 4 weeks and adapted for 8 weeks in our animal facility. BBaOK can spontaneously develop an insulin-dependent diabetes mellitus. 14 Therefore, only data from BBaOK rats which did not develop diabetes until an age of 32 weeks were included in the study. All rats were kept in groups of three in Macrolone cages (size 3, Ehret GmbH, Emmendingen, Germany) under strict hygienic conditions in the same animal unit and were free of major pathogens as described elsewhere. 14 The animals had free access to food (Ssniff R, Soest, Germany) and acidulated water and were kept in a 12 h light (5 am to 5 pm): 12 h dark cycle.
Phenotype
Body weight and body length were measured at age 14 weeks to calculating the body mass index (BMI). Blood samples were obtained by puncturing the ophthalmic venous plexus at 12, 13 and 14 weeks between 7 and 9 am to determine blood glucose, serum triglycerides, cholesterol, using an automatic analyzer (Roche Cobas Mira Plus, Basel, Switzerland), and insulin and leptin using radioimmunoassay (Rat Insulin RIA Kit and Rat Leptin RIA Kit, Linco Research Inc., St Charles, Missouri).
Statistics
Data were evaluated by using the statistical analysis system SPSS. The mean values from three measurements (12, 13 and 14 weeks) for each rat were used for statistical analysis. The values are given as mean AE s.d. Signi®cant differences between groups were checked by ANOVA analysis.
Results
All data are summarized in the Table 1 . Regarding body weight and BMI, the heaviest and largest rats were WKY and WOKW followed by BBaOK, LEW and SHR and the smallest and lightest rats were BN, signi®cantly different from all other rat strains studied. Blood glucose values in BN rats were comparable with WOKW, but signi®cantly lower than in LEW, WKY, BBaOK and SHR rats. Furthermore, BBaOK rats had signi®cantly higher blood glucose than LEW, WKY and WOKW rats. Serum insulin was signi®cantly higher in LEW, SHR, WKY and WOKW strains than in BN and BBaOK rats. Comparably high values of insulin were detected in SHR, WOKW and LEW rats. In addition, serum insulin levels in WKY were signi®cantly lower than in WOKW rats. WOKW and LEW rats were characterized by highest serum leptin values, but only values of WOKW rats were signi®cantly different from those of BN, WKY, BBaOK and SHR rats. Serum leptin levels of LEW rats were only signi®cantly different from those of BN and BBaOK rats. BN rats differed signi®cantly from all other rat strains showing the lowest leptin values. In serum lipids, WKY rats showed signi®cantly increased serum total cholesterol in comparison with all other rat strains. The LEW rat showed signi®cantly lower cholesterol values than WKY rats, but signi®-cantly higher values than BN, BBaOK, SHR and WOKW rats. Lowest cholesterol values were observed in SHR rats, signi®cantly lower than values of BBaOK and WOKW rats, respectively. Similarly, the serum triglycerides measured in SHR were comparable with BN rats, but were signi®cantly lower than in LEW, WKY, BBaOK and WOKW rats. The values of WKY were comparable with WOKW rats, although WOKW showed higher levels than WKY rats in tendency.
Discussion
Our ®ndings clearly demonstrate that each inbred rat strain studied is characterized by its own metabolic pro®le which can be attributed to genetic differences resulting in variable phenotypes. However, the results also indicate that the comparison of two rat strains in order to differentiate which of them may be an adequate model for a human metabolic disorder like obesity, hyperinsulinemia andaor dyslipidemia, is a formidable task. Using BN rats and their values as a reference for health, all other rat strains, LEW, WKY, BBaOK, SHR and WOKW, would score as being prone to obesity. This is true not only for the BMI as an estimation factor of body fat but also for the values of leptin, which is implicated in the regulation of food intake, energy expenditure, whole-body energy balance, and which is highly correlated with body fat mass. Recent data suggest that hyperleptinemia rather than hyperinsulinemia may play a crucial role in the genesis of metabolic syndrome. 2, 16 Considering additionally insulin, which is a potent stimulator of leptin expression, LEW, WKY, SHR and WOKW rats would be judged not only prone to obesity but also to hyperinsulinemia. Completing the metabolic aberrations of the syndrome, which includes also dyslipiMetabolic features in inbred rat strains J van den Brandt et al demia, LEW, WKY and WOKW rats would be considered obese, hyperinsulinemic and also dyslipidemic. However, if we choose WKY rats as diseaseresistant and use their values as healthy reference, then BN rats would be judged as suffering from anorexia, which is de®ned as an inability to maintain body weight over a minimal normal value for age and height, such as 15% below that expected. 17 In this case the mean weight of BN rats is 29% lower than that of WKY animals. Regarding additional metabolic aberrations, only WOKW rats could be used to study hyperinsulinemia connected with high leptin values because for only WOKW rats indicated signi®cantly higher insulin and leptin values than found in WKY. It could be supposed that hyperleptinemia, hypertriglyceridemia and hyperinsulinemia may simply represent a consequence of obesity. However, if one considers all the data then it is clear that the relationship between these traits is differently determined in the various strains, most likely by different genetic factors. The ®ndings of the study demonstrate the relevance of experimental design to differentiating between strains which could be appropriate models to study the underlying pathophysiology of metabolic disorder similar to the syndrome seen in human.
BN, LEW and especially WKY rats are used as disease-resistant control strain for SHR rats in studies of blood pressure and metabolic traits. 4 ± 8,11,12 Our ®ndings con®rm that SHR animals are indeed more prone than BN rats to obesity with relatively high leptin values and hyperinsulinemia, but do not support the view that SHR rats are also dyslipidemic. Total cholesterol and triglycerides were comparable between BN and SHR rats and were remarkably lower than in LEW and WKY rats, also used as disease-resistant control strains for SHR rats. This difference could be attributed to the well-known fact that there are sublines of inbred rat strains from different breeding companies which differ in genotype and therefore also in phenotype. For LEW and WKY rat sublines, analysis of polymorphisms of genetic markers have shown differences of up to 50%. 18 This fact may explain the fact that values of LEW and WKY rats of our study are obviously different from those in literature, indicating that these sublines of LEW as well as WKY rats are unsuitable as disease-resistant controls for the SHR subline used in our study. In contrast to the genotype of LEW and WKY rat sublines, SHR rat sublines were found to be mostly uniform in genotype and BN rat sublines can differ by up to 14% of the genotype. 18 These differences in genotype are obviously lower than those described for LEW and WKY rats.
Comparing therefore relatively, our data with those from the literature in BN and SHR rats, our data support the generally known fact that SHR rats are hyperinsulinemic and prone to obesity, but do not support the assumption that SHR rats are dyslipidemic. 11,19 ± 21 We have compared the relative values of BMI, leptin, insulin, cholesterol and triglycerides (value of each strain divided by the sum of all valuesÂ100) between all rat strains to get a total relative value for these traits for each strain, indicating the extent and severity of the metabolic syndrome. By this analysis, WOKW rats develop metabolic syndrome with a relative total value of 21.7% followed by WKY with 19.2%, LEW with 18.3% and SHR with 15.6%. Therefore, WOKW rat seems to be more suited than SHR as a model for the study of factors underlying the pathophysiology of the metabolic syndrome, the more so as WOKW rats are also moderately hypertensive (140 ± 150 mmHg), 22 develop an impaired glucose tolerance 10 and the syndrome is polygenetically determined like in humans which has been shown by cosegregation analysis. 23 Hypertension is also one of the main features of the metabolic syndrome. A comparative study using several inbred rat strains and wild rats was recently carried out in our laboratories and showed, that the blood pressure of LEW and BN rats was lower and the blood pressure of WKY higher than in wild rats, which were supposed to be normotensive. 24 Only the blood pressure of BBaOK rats was comparable with that of wild rats, demonstrating differences in blood pressure between so-called normotensive strains. This is consistent with ®ndings of the present study which shows differences in metabolic pro®les of the studied inbred strains. In order to characterize the metabolic features of the studied strains, emphasis was put on phenotypic traits relevant to the metabolic syndrome. Therefore, it would be desirable to examine further traits, particularly HDL-cholesterol levels and blood glucose with glucose tolerance, in order to obtain more precise metabolic pro®les of investigated rat strains.
Conclusion
Even if the results of our study may not be applicable for all commercially available strains, particularly regarding the differences in various sublines of the same strains discussed above, the study demonstrates the necessity for precise phenotypic characterization of rat strains to be used for crossing studies. Furthermore, each rat strain is characterized by its own metabolic pro®le, making it dif®cult to de®ne the most appropriate control group. Because of this the results of genetic studies have to be interpreted very carefully and according to the chosen control strain. The choice of disease-resistant inbred rat strains as healthy controls' for a disease-prone strain has to be carried out precisely to evaluate the extent and severity of a complex disease state like metabolic syndrome. Although none of studied alternative control strains seems to be adequate for genetic dissection of metabolic syndrome, the study showed that the WOKW rat develops most if not all facets of the metabolic syndrome described in human, including the highest leptin values. If hyperleptinemia rather than hyperinsulinemia plays the central role in the Metabolic features in inbred rat strains J van den Brandt et al genesis of the cardiovascular disease risk factor cluster that constitutes the metabolic syndrome, the WOKW rat seems to be more suitable than SHR to study a number of factors underlying the pathophysiology of the metabolic syndrome.
